Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Cardiovascular Research|December 1, 1993
A targeted antithrombotic conjugate with antiplatelet and fibrinolytic properties which reduces in vivo thrombus formationR S More, M J Underwood, M J Brack, et al.
Lancet (London, England)|February 15, 1992
Transcutaneous ultrasound measurement of blood-flow in internal mammary artery to coronary artery graftsD P de Bono, N J Samani, T J Spyt, et al.
International Journal of Cardiology|April 1, 1986
Clinical effects and kinetic properties of intravenous APSAC--anisoylated plasminogen-streptokinase activator complex (BRL 26921) in acute myocardial infarctionM Been, D P de Bono, A L Muir, et al.
Circulation|December 15, 1996
Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibodyR K Aggarwal, D C Ireland, M A Azrin, et al.
European Heart Journal|July 1, 1996
Reproducibility and automatic measurement of QT dispersionJ M Glancy, P J Weston, H K Bhullar, et al.
British Heart Journal|January 1, 1988
Serial changes in the T1 magnetic relaxation parameter after myocardial infarction in manM Been, M A Smith, J P Ridgway, et al.
Journal of the American College of Cardiology|January 1, 1991
Reasons for the lack of benefit of immediate angioplasty during recombinant tissue plasminogen activator therapy for acute myocardial infarction: a regional wall motion analysis. European Cooperative Study GroupA E Arnold, P W Serruys, W Rutsch, et al.
Lancet (London, England)|April 13, 1985
Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen ActivatorM Verstraete, R Bernard, M Bory, et al.
Cardiovascular Research|July 27, 2000
In vitro evaluation of c7E3-Fab (ReoPro) eluting polymer-coated coronary stentsJ H Baron, A H Gershlick, K Hogrefe, et al.
Circulation|July 1, 1992
Recombinant tissue-type plasminogen activator and immediate angioplasty in acute myocardial infarction. One-year follow-up. The European Cooperative Study GroupA E Arnold, M L Simoons, F Van de Werf, et al.
Pageof 9